TLR4 and acute respiratory distress syndrome: Dexmedetomidine is a highly potent and selective α2-adrenoceptor agonist, apart from its well-established sedative and analgesic properties, it has been shown to ameliorate septic ALI by inhibiting the release of pro-inflammatory cytokines mediated by TLR4/ NF-κB signaling pathway.